PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-8.13%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-13.11%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-12.58%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-73.23%
Negative net income growth while QRVO stands at 171.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-72.87%
Negative EPS growth while QRVO is at 170.97%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-73.02%
Negative diluted EPS growth while QRVO is at 169.35%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.30%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.10%
Reduced diluted shares while QRVO is at 3.27%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
23.81%
Dividend growth of 23.81% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
12.02%
Similar OCF growth to QRVO's 12.12%. Walter Schloss would assume comparable operations or industry factors.
10.55%
Positive FCF growth while QRVO is negative. John Neff would see a strong competitive edge in net cash generation.
46.89%
10Y revenue/share CAGR above 1.5x QRVO's 19.97%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
42.24%
5Y revenue/share CAGR above 1.5x QRVO's 19.97%. David Dodd would look for consistent product or market expansions fueling outperformance.
21.89%
3Y revenue/share CAGR under 50% of QRVO's 194.87%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
88.82%
10Y OCF/share CAGR under 50% of QRVO's 1136.17%. Michael Burry would worry about a persistent underperformance in cash creation.
100.89%
Below 50% of QRVO's 1136.17%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
61.14%
3Y OCF/share CAGR under 50% of QRVO's 814.41%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-36.54%
Negative 10Y net income/share CAGR while QRVO is at 283.39%. Joel Greenblatt sees a major red flag in long-term profit erosion.
47.24%
Below 50% of QRVO's 283.39%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-55.69%
Negative 3Y CAGR while QRVO is 6374.95%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
44.34%
Below 50% of QRVO's 301.19%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.56%
Below 50% of QRVO's 301.19%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.71%
Below 50% of QRVO's 749.97%. Michael Burry suspects a serious short-term disadvantage in building book value.
516.71%
Dividend/share CAGR of 516.71% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
193.79%
Dividend/share CAGR of 193.79% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
82.37%
3Y dividend/share CAGR of 82.37% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-18.91%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.57%
Inventory shrinking or stable vs. QRVO's 6.39%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
4.21%
Positive asset growth while QRVO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-5.64%
We have a declining book value while QRVO shows 0.99%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
13.79%
Debt growth far above QRVO's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
2.93%
R&D growth drastically higher vs. QRVO's 3.32%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.73%
We cut SG&A while QRVO invests at 1.58%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.